Laronde

About:

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Twitter/X: endlessRNA

Top Investors: BlackRock, Fidelity, Invus, Flagship Pioneering, Federated Kaufmann Fund

Description:

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

Total Funding Amount:

$490M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)laronde.bio

Founders:

Avak Kahvejian, Erica Weinstein, Nick Plugis, Noubar Afeyan, Sophie de Boer, Yann Echelard

Number of Employees:

11-50